In 2023, the 18A segment of the Hong Kong stock market enters its fifth year of listing, and the fifth set of standards for the Sci-tech Innovation Board enters its fourth year. A total of 85 biotech companies have successfully gone public through this listing channel, driving the entire life science sector into high gear. Having experienced both a boom and a frenzy, as well as a cold winter and rationality, life science companies have never stopped innovating and breaking through. They continuously inject development momentum through technological innovation and bridge gaps through business model innovation. After experiencing dark moments, they still see themselves standing at a new starting point and forging ahead.
From September 27th to 28th, Frost & Sullivan (Frost & Sullivan, abbreviated as: Frost & Sullivan) will grandly host its second New Investment Expo and the 17th Frost & Sullivan Global Growth, Sci-tech Innovation, and Leadership Summit (abbreviated as "Frost & Sullivan New Investment Conference"), which will be held at the Shangri-La Hotel in Pudong, Shanghai. The conference will launch theLife Science New Investment Summit Forumwith the theme of“New Directions for the Future & Forging Ahead”bringing togetherindustry leaders, life science companies, investment institutions, and professional service providersto focus on new investment and financing opportunities in life sciences and jointly discuss the capital and industrial forces for enterprises to navigate cycles.
We sincerely invite you to attend this forum and embark on the successful journey of the capital market for life science companies!
Time:September 27th - 28th, 2023
Venue:Shangri-La Hotel in Pudong, Shanghai
Sponsors:Frost & Sullivan, China Biomedical Industry Chain Innovation and Transformation Alliance (CBIITA)
About Shurui Shares
Beijing Shurui Robot Co., Ltd. ("Shurui Shares" or "Company") is a high-tech medical device enterprise dedicated to independently researching, developing, producing, and commercializing minimally invasive laparoscopic surgical robot systems and supporting instrument products with global leading advantages. The company's products can be applied in urology and have already undergone registration clinical trials in gynecology and general surgery. In the future, they plan to expand to departments such as thoracic and cardiac surgery, providing patients with minimally invasive surgical solutions that are less traumatic, more precise, and safer.
In June 2023, the National Medical Products Administration approved the company's innovative product registration application for the intraperitoneal endoscopic single-port surgical system (SR-ENS-600). This product can be used for laparoscopic surgical operations in urology and is the first and currently only surgical robot approved for marketing in the domestic single-port laparoscopic field, effectively filling a domestic gap. The surgical instruments in this product adopt innovative technologies that are internationally pioneering and have independent intellectual property rights, with technical advantages such as wide range of motion, strong load capacity, and high reliability. Doctors can use the unique control system of this product to improve the level of operation refinement, reduce surgical trauma, and provide patients with safer, more precise, and less traumatic minimally invasive surgical solutions.
The surgical instrument arms of the company's intraperitoneal endoscopic single-port surgical system rely on the innovative design of the "Deformation-driven Control Technology for Continuous Bodies," which is internationally pioneering and has independent intellectual property rights. The surgical instruments and endoscopic tool arms configured in the system are equipped with high-performance deformable structural arms made of nickel-titanium alloy material, breaking the technical monopoly of foreign manufacturers in the field of single-port laparoscopic surgical robots.
Introduction to Speakers
Xu Kai, founder of Beijing Shurui Robot Co., Ltd., professor and doctoral supervisor at Shanghai Jiao Tong University. Outstanding Young Scholar of the National Natural Science Foundation of China, specially invited expert at Beijing Haiju, outstanding talent in the new century of the Ministry of Education, and talent at Shanghai Pujiang. Bachelor's and master's degree from Tsinghua University, doctorate from Columbia University in the United States, and has received the highest Distinguished President's Scholarship from Columbia University and the China National Scholarship for Outstanding Self-funded International Students. He has presided over four projects of the National Natural Science Foundation of China and one special project of the Key Research and Development Program of the Ministry of Science and Technology, published more than 100 SCI/EI papers, and obtained more than 60 invention patents authorized at home and abroad. He serves as an associate editor of the world's top robotics journalIEEE Transactions on Roboticsand an international expert on standards for the International Committee on Standardization.
01
Consultation for Participation
Registration Consultation | Business Cooperation | Media Cooperation
Contact Person:
Ms. Li 18917935734 (same WeChat)
Ms. Bai 18019047843 (same WeChat)
03
Highlights from Previous Sessions
